Value of ultra-high b-value diffusion-weighted imaging combined with T2-weighted imaging in the diagnosis of peripheral prostate cancer
刘健萍,贺小红,金亚彬,林胜强,高明勇,李斌
DOI: https://doi.org/10.3760/cma.j.cn121381-201910023-00036
2020-01-01
Abstract:Objective:To investigate the clinical value of ultra-high b-value diffusion-weighted imaging (DWI) combined with T2-weighted imaging (T2WI) in the diagnosis of peripheral prostate cancer (PCa).Methods:Forty-one patients who underwent ultrasound-guided prostate target puncture, clinicopathological diagnosis, and prostate MRI within one month before and after the puncture were selected from December 1, 2018 to October 1, 2019 in the First People's Hospital of Foshan. The patients' ages ranged from 49 to 89 years, with a median age of 69 years. All of the patients completed 3.0T ultra-high b-value DWI and T2WI fat suppression (2000 and 3000 s/mm
2, respectively). With prostate target puncture pathology as the gold standard, the sensitivity, specificity, accuracy, and area under the receiver operating characteristic (ROC) curve were calculated for the different imaging methods in PCa diagnosis.
Results:Among all the 41 patients, 26 had PCa (the 26 cases were peripheral zone PCa confirmed by clinical diagnosis and puncture site location) and 15 had benign hyperplasia. The sensitivity of T2WI, DWI (b=2000 s/mm
2), DWI (b=3000 s/mm
2), T2WI+DWI (b=2000 s/mm
2), and T2WI+DWI (b=3000 s/mm
2) in PCa diagnosis was 0.962 (25/26), 0.962 (25/26), 0.962 (25/26), 0.923 (24/26), and 0.923 (24/26) respectively; the specificity was 0.400 (6/15), 0.667 (10/15), 0.876 (13/15), 0.800 (12/15), and 1.000 (15/15), respectively; the accuracy was 0.756 (31/41), 0.854 (35/41), 0.926 (38/41), 0.878 (36/41), and 0.951 (39/41), respectively; and the area under the ROC curve was 0.681, 0.814, 0.914, 0.872, and 0.972(
P=0.056, 0.001, <0.001, <0.001, <0.001), respectively.
Conclusions:DWI (b=3000 s/mm
2) combined with the T2WI image exhibited high accuracy in PCa diagnosis. It is expected to become a highly reliable noninvasive examination procedure for the diagnosis of PCa.